First Time Loading...
C

Clarus Therapeutics Holdings Inc
NASDAQ:CRXT

Watchlist Manager
Clarus Therapeutics Holdings Inc
NASDAQ:CRXT
Watchlist
Price: 0.021 USD -19.54%
Updated: May 15, 2024

Clarus Therapeutics Holdings Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Clarus Therapeutics Holdings Inc
Gross Profit Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
C
Clarus Therapeutics Holdings Inc
NASDAQ:CRXT
Gross Profit
$11.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Gross Profit
$59.6B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Gross Profit
$34.6B
CAGR 3-Years
2%
CAGR 5-Years
16%
CAGR 10-Years
11%
Pfizer Inc
NYSE:PFE
Gross Profit
$38.8B
CAGR 3-Years
55%
CAGR 5-Years
N/A
CAGR 10-Years
-1%
Merck & Co Inc
NYSE:MRK
Gross Profit
$46B
CAGR 3-Years
17%
CAGR 5-Years
9%
CAGR 10-Years
6%
Eli Lilly and Co
NYSE:LLY
Gross Profit
$28.8B
CAGR 3-Years
14%
CAGR 5-Years
11%
CAGR 10-Years
5%

See Also

What is Clarus Therapeutics Holdings Inc's Gross Profit?
Gross Profit
11.2m USD

Based on the financial report for Dec 31, 2021, Clarus Therapeutics Holdings Inc's Gross Profit amounts to 11.2m USD.